Resmed Inc
SWB:RMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Resmed Inc (RMEA) under the Base Case is EUR per share.
Compared with the current market price of 21.4 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Resmed Does
Resmed makes devices and software for people with sleep apnea, COPD, and other breathing disorders. Its main products are CPAP and bilevel machines, masks, and other patient interface products that help people breathe more easily at home while they sleep. It also sells cloud-connected software that helps doctors, sleep clinics, and home medical equipment providers track treatment and manage patients.
- Headquarters
- United States of America US
- Employees
- 10 600
- IPO date
- Jun 1, 1995
Resmed has a narrow economic moat
Patents limit direct copying of Resmed’s breathing devices and masks, while its software makes replacing established care systems time-consuming. These protections help it retain customers, although rivals can still compete with different product designs.
Read the full moat analysisContinue RMEA Research
Decided on Resmed? Get an email when RMEA reaches the price you’d buy at. Free with an account.
Other Resmed listings
What is the Intrinsic Value of one RMEA stock?
The intrinsic value for
Resmed Inc (RMEA) under the Base Case is EUR.
Is RMEA stock undervalued or overvalued?
Compared with the current market price of 21.4 EUR, the stock appears .